Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure

Molecular and Cellular Biology

Volumn 30, Issue 7, 2010, Pages 1746-1756

  Lara, Aline ^a   Damasceno, Denis D ^a   Pires, Rita ^b   Gros, Robert ^b,e   Gomes, Enéas R ^a   Gavioli, Mariana ^a   Lima, Ricardo F ^a   Guimarães, Diogo ^a   Lima, Patricia ^a   Bueno Jr , Carlos Roberto ^c   Vasconcelos, Anilton ^a   Roman Campos, Danilo ^a   Menezes, Cristiane A S ^b   Sirvente, Raquel A ^c   Salemi, Vera M ^c   Mady, Charles ^c   Caron, Marc G ^d   Ferreira, Anderson J ^a   Brum, Patricia C ^c   Resende, Rodrigo R ^a   Cruz, Jader S ^a   Gomez, Marcus Vinicius ^a   Prado, Vania F ^b,e   De Almeida, Alvair P ^a   Prado, Marco A M ^b,e   Guatimosim, Silvia ^a   more..

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; G PROTEIN COUPLED RECEPTOR; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE RELEASE; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DYSAUTONOMIA; GENE EXPRESSION; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART RATE; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; ISOLATED HEART; M MODE ECHOCARDIOGRAPHY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

MUS;

EID: 77949342114     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00996-09     Document Type: Article

References (51)

1. Amorim, D. S., H. J. Dargie, K. Heer, M. Brown, D. Jenner, E. G. Olsen, P. Richardson, and J. F. Goodwin. 1981. Is there autonomic impairment in congestive (dilated) cardiomyopathy? Lancet i:525-527.
2. Bartholomeu, J. B., A. S. Vanzelli, N. P. Rolim, J. C. Ferreira, L. R. Bechara, L. Y. Tanaka, K. T. Rosa, M. M. Alves, A. Medeiros, K. C. Mattos, M. A. Coelho, M. C. Irigoyen, E. M. Krieger, J. E. Krieger, C. E. Negrao, P. R. Ramires, S. Guatimosim, and P. C. Brum. 2008. Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure. J. Mol. Cell. Cardiol. 45:240-249.
3. Bers, D. M. 2006. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 21:380-387.
4. Bers, D. M. 2002. Cardiac excitation-contraction coupling. Nature 415:198-205.
5. Brandon, E. P., W. Lin, K. A. D'Amour, D. P. Pizzo, B. Dominguez, Y. Sugiura, S. Thode, C. P. Ko, L. J. Thal, F. H. Gage, and K. F. Lee. 2003. Aberrant patterning of neuromuscular synapses in choline acetyltransferasedeficient mice. J. Neurosci. 23:539-549.
6. Castro, C. H., R. A. Santos, A. J. Ferreira, M. Bader, N. Alenina, and A. P. Almeida. 2005. Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension 46:937-942.
7. Chakir, K., S. K. Daya, T. Aiba, R. S. Tunin, V. L. Dimaano, T. P. Abraham, K. M. Jaques-Robinson, E. W. Lai, K. Pacak, W. Z. Zhu, R. P. Xiao, G. F. Tomaselli, and D. A. Kass. 2009. Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation 119:1231- 1240.
8. Cruz, J. S., and H. Matsuda. 1994. Depressive effects of arenobufagin on the delayed rectifier K+ current of guinea-pig cardiac myocytes. Eur. J. Pharmacol. 266:317-325.
9. de Castro, B. M., X. De Jaeger, C. Martins-Silva, R. D. Lima, E. Amaral, C. Menezes, P. Lima, C. M. Neves, R. G. Pires, T. W. Gould, I. Welch, C. Kushmerick, C. Guatimosim, I. Izquierdo, M. Cammarota, R. J. Rylett, M. V. Gomez, M. G. Caron, R. W. Oppenheim, M. A. Prado, and V. F. Prado. 2009. The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol. Cell. Biol. 29:5238-5250.
10. de Castro, B. M., G. S. Pereira, V. Magalhaes, J. I. Rossato, X. De Jaeger, C. Martins-Silva, B. Leles, P. Lima, M. V. Gomez, R. R. Gainetdinov, M. G. Caron, I. Izquierdo, M. Cammarota, V. F. Prado, and M. A. Prado. 2009. Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes Brain Behav. 8:23-35.
11. De Meersman, R. E., and P. K. Stein. 2007. Vagal modulation and aging. Biol. Psychol. 74:165-173.
12. Dhein, S., C. J. van Koppen, and O. E. Brodde. 2001. Muscarinic receptors in the mammalian heart. Pharmacol. Res. 44:161-182.
13. Duprez, D. A. 2008. Cardiac autonomic imbalance in pre-hypertension and in a family history of hypertension. J. Am. Coll. Cardiol. 51:1902-1903.
14. Ferreira, A. J., T. L. Oliveira, M. C. Castro, A. P. Almeida, C. H. Castro, M. V. Caliari, E. Gava, G. T. Kitten, and R. A. Santos. 2007. Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991. Life Sci. 81:916-923.
15. Floras, J. S. 1993. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J. Am. Coll. Cardiol. 22:72A-84A.
16. Freeling, J., K. Wattier, C. LaCroix, and Y. F. Li. 2008. Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. Exp. Physiol. 93:75-82.
17. Funakoshi, H., T. Kubota, N. Kawamura, Y. Machida, A. M. Feldman, H. Tsutsui, H. Shimokawa, and A. Takeshita. 2002. Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ. Res. 90:959-965.
18. Gehrmann, J., P. E. Hammer, C. T. Maguire, H. Wakimoto, J. K. Triedman, and C. I. Berul. 2000. Phenotypic screening for heart rate variability in the mouse. Am. J. Physiol. Heart Circ. Physiol. 279:H733-H740.
19. Grassi, G., G. Seravalle, F. Quarti-Trevano, and R. Dell'oro. 2009. Sympathetic activation in congestive heart failure: evidence, consequences and therapeutic implications. Curr. Vasc. Pharmacol. 7:137-145.
20. Gros, R., X. You, L. L. Baggio, M. G. Kabir, A. M. Sadi, I. N. Mungrue, T. G. Parker, Q. Huang, D. J. Drucker, and M. Husain. 2003. Cardiac function in mice lacking the glucagon-like peptide-1 receptor. Endocrinology 144:2242-2252.
21. Guatimosim, S., E. A. Sobie, C. J. dos Santos, L. A. Martin, and W. J. Lederer. 2001. Molecular identification of a TTX-sensitive Ca(2+) current. Am. J. Physiol. Cell Physiol. 280:C1327-C1339.
22. Ishise, H., H. Asanoi, S. Ishizaka, S. Joho, T. Kameyama, K. Umeno, and H. Inoue. 1998. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J. Appl. Physiol. 84:1234-1241.
23. Kakinuma, Y., T. Akiyama, and T. Sato. 2009. Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium. FEBS J. 276:5111-5125.
24. Kent, K. M., S. E. Epstein, T. Cooper, and D. M. Jacobowitz. 1974. Cholinergic innervation of the canine and human ventricular conducting system. Anatomic and electrophysiologic correlations. Circulation 50:948-955.
25. Korth, M., V. K. Sharma, and S. S. Sheu. 1988. Stimulation of muscarinic receptors raises free intracellular Ca2+ concentration in rat ventricular myocytes. Circ. Res. 62:1080-1087.
26. LaCroix, C., J. Freeling, A. Giles, J. Wess, and Y. F. Li. 2008. Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. Am. J. Physiol. Heart Circ. Physiol. 294:H810-H820.
27. Lanzafame, A. A., A. Christopoulos, and F. Mitchelson. 2003. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors Channels 9:241-260.
28. Li, M., C. Zheng, T. Sato, T. Kawada, M. Sugimachi, and K. Sunagawa. 2004. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109:120-124.
29. Lloyd-Mostyn, R. H., and P. J. Watkins. 1975. Defective innervation of heart in diabetic autonomic neuropathy. Br. Med. J. 3:15-17.
30. Mabe, A. M., J. L. Hoard, M. M. Duffourc, and D. B. Hoover. 2006. Localization of cholinergic innervation and neurturin receptors in adult mouse heart and expression of the neurturin gene. Cell Tissue Res. 326:57-67.
31. Martini, J. S., P. Raake, L. E. Vinge, B. DeGeorge, Jr., J. K. Chuprun, D. M. Harris, E. Gao, A. D. Eckhart, J. A. Pitcher, and W. J. Koch. 2008. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 105:12457-12462.
32. Misgeld, T., R. W. Burgess, R. M. Lewis, J. M. Cunningham, J. W. Lichtman, and J. R. Sanes. 2002. Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. Neuron 36:635-648.
33. Mungrue, I. N., R. Gros, X. You, A. Pirani, A. Azad, T. Csont, R. Schulz, J. Butany, D. J. Stewart, and M. Husain. 2002. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest. 109:735-743.
34. Nagata, K., C. Ye, M. Jain, D. S. Milstone, R. Liao, and R. M. Mortensen. 2000. Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes. Circ. Res. 87:903-909.
35. Okoshi, K., M. Nakayama, X. Yan, M. P. Okoshi, A. J. Schuldt, M. A. Marchionni, and B. H. Lorell. 2004. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion. Circulation 110:713-717.
36. Oliveira, F. A., S. Guatimosim, C. H. Castro, D. T. Galan, S. Lauton-Santos, A. M. Ribeiro, A. P. Almeida, and J. S. Cruz. 2007. Abolition of reperfusioninduced arrhythmias in hearts from thiamine-deficient rats. Am. J. Physiol. Heart Circ. Physiol. 293:H394-H401.
37. Olshansky, B., H. N. Sabbah, P. J. Hauptman, and W. S. Colucci. 2008. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118:863-871.
38. Pandya, K., H. S. Kim, and O. Smithies. 2006. Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo. Proc. Natl. Acad. Sci. U. S. A. 103:16864- 16869.
39. Penela, P., C. Murga, C. Ribas, A. S. Tutor, S. Peregrin, and F. Mayor, Jr. 2006. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc. Res. 69:46-56.
40. Petrofski, J. A., and W. J. Koch. 2003. The beta-adrenergic receptor kinase in heart failure. J. Mol. Cell. Cardiol. 35:1167-1174.
41. Prado, V. F., C. Martins-Silva, B. M. de Castro, R. F. Lima, D. M. Barros, E. Amaral, A. J. Ramsey, T. D. Sotnikova, M. R. Ramirez, H. G. Kim, J. I. Rossato, J. Koenen, H. Quan, V. R. Cota, M. F. Moraes, M. V. Gomez, C. Guatimosim, W. C. Wetsel, C. Kushmerick, G. S. Pereira, R. R. Gainetdinov, I. Izquierdo, M. G. Caron, and M. A. Prado. 2006. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51:601-612.
42. Rota, M., T. Hosoda, A. De Angelis, M. L. Arcarese, G. Esposito, R. Rizzi, J. Tillmanns, D. Tugal, E. Musso, O. Rimoldi, C. Bearzi, K. Urbanek, P. Anversa, A. Leri, and J. Kajstura. 2007. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ. Res. 101:387-399.
43. Serra, S. M., R. V. Costa, R. R. Teixeira De Castro, S. S. Xavier, and A. C. Nobrega. 2009. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. J. Card. Fail. 15:124-129.
44. Sharma, V. K., H. M. Colecraft, L. E. Rubin, and S. S. Sheu. 1997. Does mammalian heart contain only the M2 muscarinic receptor subtype? Life Sci. 60:1023-1029.
45. Sharma, V. K., H. M. Colecraft, D. X. Wang, A. I. Levey, E. V. Grigorenko, H. H. Yeh, and S. S. Sheu. 1996. Molecular and functional identification of m1 muscarinic acetylcholine receptors in rat ventricular myocytes. Circ. Res. 79:86-93.
46. Spragg, D. D., and D. A. Kass. 2006. Pathobiology of left ventricular dyssynchrony and resynchronization. Prog. Cardiovasc. Dis. 49:26-41.
47. Thayer, J. F., and R. D. Lane. 2007. The role of vagal function in the risk for cardiovascular disease and mortality. Biol. Psychol. 74:224-242.
48. Vikstrom, K. L., T. Bohlmeyer, S. M. Factor, and L. A. Leinwand. 1998. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ. Res. 82:773-778.
49. Wang, Z., H. Shi, and H. Wang. 2004. Functional M3 muscarinic acetylcholine receptors in mammalian hearts. Br. J. Pharmacol. 142:395-408.
50. Wu, J. S., F. H. Lu, Y. C. Yang, T. S. Lin, J. J. Chen, C. H. Wu, Y. H. Huang, and C. J. Chang. 2008. Epidemiological study on the effect of pre-hypertension and family history of hypertension on cardiac autonomic function. J. Am. Coll. Cardiol. 51:1896-1901.
51. Yang, L. L., R. Gros, M. G. Kabir, A. Sadi, A. I. Gotlieb, M. Husain, and D. J. Stewart. 2004. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 109:255-261.